8PM9
Crystal structure of human wild type transthyretin in complex with PITB (Pharmacokinetically Improved TTR Binder)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALBA BEAMLINE XALOC |
Synchrotron site | ALBA |
Beamline | XALOC |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2022-02-19 |
Detector | DECTRIS PILATUS3 6M |
Wavelength(s) | 0.979260 |
Spacegroup name | P 21 2 21 |
Unit cell lengths | 43.504, 64.089, 84.780 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 42.390 - 1.850 |
R-factor | 0.1944 |
Rwork | 0.193 |
R-free | 0.21860 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.006 |
RMSD bond angle | 0.843 |
Data reduction software | XDS |
Data scaling software | Aimless ((0.7.7)) |
Phasing software | PHENIX |
Refinement software | PHENIX ((1.17.1_3660: ???)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 43.500 | 1.890 |
High resolution limit [Å] | 1.850 | 1.850 |
Number of reflections | 20915 | 8398 |
<I/σ(I)> | 14.8 | |
Completeness [%] | 99.9 | 100 |
Redundancy | 6.3 | |
CC(1/2) | 0.999 | 0.692 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 8 | 291.15 | 0.1M HEPES pH8, 0.2M CaCl2, 25% PEG 400 |